Organon & Co.
OGN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $4 | $4 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $9 | $9 | $9 | $9 |
| Enterprise Value | $12 | $11 | $12 | $12 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 0.5% | 5.4% | -5% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 53.5% | 54.8% | 55.6% | 56.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28.7% | 28.2% | 21.5% | 21.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 10% | 9.1% | 5.8% | 6.8% |
| EPS Diluted | 0.61 | 0.56 | 0.33 | 0.42 |
| % Growth | 8.9% | 69.7% | -21.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |